- Home
- ADAG vs CGO Comparison
ADAG vs CGO Comparison
Compare ADAG & CGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAG
- CGO
- Stock Information
- Founded
- ADAG 2011
- CGO 2004
- Country
- ADAG China
- CGO United States
- Employees
- ADAG N/A
- CGO N/A
- Industry
- ADAG Biotechnology: Pharmaceutical Preparations
- CGO Investment Managers
- Sector
- ADAG Health Care
- CGO Finance
- Exchange
- ADAG Nasdaq
- CGO Nasdaq
- Market Cap
- ADAG 110.8M
- CGO 115.6M
- IPO Year
- ADAG 2021
- CGO N/A
- Fundamental
- Price
- ADAG $2.24
- CGO $12.15
- Analyst Decision
- ADAG Strong Buy
- CGO
- Analyst Count
- ADAG 2
- CGO 0
- Target Price
- ADAG $7.00
- CGO N/A
- AVG Volume (30 Days)
- ADAG 140.2K
- CGO 34.7K
- Earning Date
- ADAG 08-12-2025
- CGO 01-01-0001
- Dividend Yield
- ADAG N/A
- CGO 9.25%
- EPS Growth
- ADAG N/A
- CGO N/A
- EPS
- ADAG N/A
- CGO N/A
- Revenue
- ADAG $103,204.00
- CGO N/A
- Revenue This Year
- ADAG $9,789.15
- CGO N/A
- Revenue Next Year
- ADAG $29.92
- CGO N/A
- P/E Ratio
- ADAG N/A
- CGO N/A
- Revenue Growth
- ADAG N/A
- CGO N/A
- 52 Week Low
- ADAG $1.33
- CGO $7.90
- 52 Week High
- ADAG $3.58
- CGO $10.93
- Technical
- Relative Strength Index (RSI)
- ADAG 52.00
- CGO 69.06
- Support Level
- ADAG $2.24
- CGO $11.56
- Resistance Level
- ADAG $2.49
- CGO $12.20
- Average True Range (ATR)
- ADAG 0.22
- CGO 0.16
- MACD
- ADAG 0.00
- CGO 0.04
- Stochastic Oscillator
- ADAG 14.81
- CGO 92.42
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.
About CGO Calamos Global Total Return Fund
Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in equities, convertible securities, and high-yield corporate bonds.